Pharma Reviews: Govt needs to consider setting up of IDA on par with US FDA to implement new Pharmaceutical ...

The implementation of the latest Pharmaceutical Policy which is now in its draft stage requires a strong and single department known as Indian Drugs ...
Read more: Govt needs to consider setting up of IDA on par with US FDA to implement new Pharmaceutical ...

Pharma Reviews: Top pharma cos back NPPA on draft policy

Drug industry body Indian Pharmaceutical Alliance (IPA) has surprisingly rallied behind the existing structure of drug prices regulator, NPPA, saying ...
Read more: Top pharma cos back NPPA on draft policy

Pharma Reviews: Market Live: Sensex, Nifty trade flat, ONGC, Sun Pharma, Infosys, Coal India major losers

Shares in state-run power utility, NTPC Ltd, dropped as much as 2.5%, after the Indian government sold some of its stake in the company to help meet ...
Read more: Market Live: Sensex, Nifty trade flat, ONGC, Sun Pharma, Infosys, Coal India major losers

US FDA News: Statement from Center for Drug Evaluation and Research Director Janet Woodcock regarding safety concerns related to investigational use of Keytruda in multiple myeloma

Statement from Center for Drug Evaluation and Research Director Janet Woodcock regarding safety concerns related to investigational use of Keytruda in multiple myeloma
Read more: Statement from Center for Drug Evaluation and Research Director Janet Woodcock regarding safety concerns related to investigational use of Keytruda in multiple myeloma

Pharma Reviews: India's FDI Policy for 2017: Startups and Single Brand Retail among Beneficiaries

Extension of FDI in the pharmaceutical sector: Up to 74 percent FDI will allowed in India's pharmaceutical sector through automatic route; beyond that ...
Read more: India's FDI Policy for 2017: Startups and Single Brand Retail among Beneficiaries

Pharma Reviews: Pharma body IPA backs NPPA on draft proposal

Mumbai: Drug industry body Indian Pharmaceutical Alliance (IPA) has surprisingly rallied behind the existing structure of drug prices regulator, NPPA, ...
Read more: Pharma body IPA backs NPPA on draft proposal

US FDA News: Doctor Manzanilla Cough & Cold and Doctor Manzanilla Allergy & Decongestant Relief Syrup: Recall - Potential Contamination with Burkholderia cepacia

Contaminated products with Burkholderia cepacia can potentially result in serious infections, may be life-threating in patients with compromised immune systems.
Read more: Doctor Manzanilla Cough & Cold and Doctor Manzanilla Allergy & Decongestant Relief Syrup: Recall - Potential Contamination with Burkholderia cepacia

US FDA News: Piyanping Anti-Itch Lotion: Recall - Incorrect Active Ingredient

There is a reasonable probability of the following side effects of topical steroids which include but are not limited to skin changes, adrenal suppression, glaucoma, and cataracts.
Read more: Piyanping Anti-Itch Lotion: Recall - Incorrect Active Ingredient

Pharma Reviews: Draft Pharmaceutical Policy 2017 : Needs more clarity and clear road maps

There have been only one Greenfield FDI project in pharma sector since the liberalisation of FDI in India. This admission raises questions on the move ...
Read more: Draft Pharmaceutical Policy 2017 : Needs more clarity and clear road maps

Pharma Reviews: ICRA ratings for Indian debt instruments-Aug 30

ICRA ratings for Indian debt instruments-Aug 30 ... Quattro Engineering India Ltd Non-FBL ICRA A4 30 Reaffirmed Sun Pharmaceutical Industries CP ...
Read more: ICRA ratings for Indian debt instruments-Aug 30

Pharma Reviews: Under pressure: A day in the grueling life of a pharma representative selling medicines in Delhi

A pharmaceutical representative entering a doctor's clinic in Pune in 2012. ... Federation of Medical and Sales Representatives' Association of India).
Read more: Under pressure: A day in the grueling life of a pharma representative selling medicines in Delhi

Pharma Reviews: Aurobindo Pharma retreats after bright start

Shares of Aurobindo Pharma Limited opened on a firm note and after ... could be the biggest overseas acquisition by an Indian pharma company.
Read more: Aurobindo Pharma retreats after bright start

Pharma Reviews: Zydus gets final USFDA nod for Aspirin, anti-blood clotting drug

Indian pharmaceutical major Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market ...
Read more: Zydus gets final USFDA nod for Aspirin, anti-blood clotting drug

Pharma Reviews: Aurobindo Pharma in talks to buy Russian business of Shreya Life Sciences

Aurobindo Pharma Ltd. with presence in over 125 countries is one of the ... be one of the biggest acquisition by an Indian pharmaceutical company.
Read more: Aurobindo Pharma in talks to buy Russian business of Shreya Life Sciences

Pharma Reviews: How is the draft pharma policy revamping drug price regulation?

The draft policy spends a lot of bytes on India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA). So let us focus on that first.
Read more: How is the draft pharma policy revamping drug price regulation?

US FDA News: Forced Air Thermal Regulating Systems: Healthcare Provider Letter - Information About Use

FDA continues to recommend the use of thermoregulating devices (including forced air thermal regulating systems) for surgical procedures when clinically warranted.
Read more: Forced Air Thermal Regulating Systems: Healthcare Provider Letter - Information About Use

US FDA News: FDA approval brings first gene therapy to the United States

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
Read more: FDA approval brings first gene therapy to the United States

Pharma Reviews: Aurobindo Pharma in talks to buy Shreya Life Sciences's Russia business

Mumbai: Aurobindo Pharma Ltd is in talks to buy the Russia business of ... could be the biggest overseas acquisition by an Indian pharma company.
Read more: Aurobindo Pharma in talks to buy Shreya Life Sciences's Russia business

US FDA News: FDA approves new antibacterial drug

The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
Read more: FDA approves new antibacterial drug

US FDA News: FDA approves first U.S. treatment for Chagas disease

The U.S. Food and Drug Administration today granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease.
Read more: FDA approves first U.S. treatment for Chagas disease

Pharma Reviews: India's public health and the looming threat of US pharma giants

Against this disturbing backdrop, the latest decision of the Indian patent office to grant a patent to the US pharmaceutical behemoth Pfizer for ...
Read more: India's public health and the looming threat of US pharma giants

Pharma Reviews: Drug firms demand NPPA withdraw notices alleging overcharging

New Delhi: The Indian Pharmaceutical Alliance (IPA), a lobby group representing local drug makers, has written to the department of pharmaceuticals ...
Read more: Drug firms demand NPPA withdraw notices alleging overcharging

Pharma Reviews: Cipla an outlier among pharma majors

The June quarter (Q1) was a forgettable one for Indian pharma majors, ... So, what makes it stand out in an industry which has long been struggling ...
Read more: Cipla an outlier among pharma majors

US FDA News: Implantable Cardiac Pacemakers by Abbott (formerly St. Jude Medical): Safety Communication - Firmware Update to Address Cybersecurity Vulnerabilities

Vulnerabilities, if exploited, could allow an unauthorized user to access patient's device, which could result in patient harm from rapid battery depletion or administration of inappropriate pacing.
Read more: Implantable Cardiac Pacemakers by Abbott (formerly St. Jude Medical): Safety Communication - Firmware Update to Address Cybersecurity Vulnerabilities

Pharma Reviews: India to take up issues faced by generic drugs exporters with US

It is not acceptable,” the official said. The US is the one of the largest markets for Indian pharma firms, with exports reaching about $5 billion in FY17.
Read more: India to take up issues faced by generic drugs exporters with US

Pharma Reviews: FDA hikes fee for processing ANDA by USD 1 lakh for FY18

The move will hurt the Indian pharma industry which is heavily dependent on the US market for exports, said a top official of Pharmaceuticals Export ...
Read more: FDA hikes fee for processing ANDA by USD 1 lakh for FY18

Pharma Reviews: New Draft Pharma Policy Seeks to Dilute the Powers of India's Drug Price Regulator

The policy proposes changes in the role and function of the National Pharmaceutical Pricing Authority, as well as to its overall structure, which will ...
Read more: New Draft Pharma Policy Seeks to Dilute the Powers of India's Drug Price Regulator

Pharma Reviews: India A Green Spot For Healthcare Industry

Celebrating the growth and revolution of Indian Healthcare industry, leading ... and professionals in the Pharmaceutical and Medical Devices sector.
Read more: India A Green Spot For Healthcare Industry

Pharma Reviews: Live Stock Market Updates – Nifty extends losses, Sensex sheds over 300 points

The INDIA VIX is up 9.1% at 13.8.The S&P BSE Sensex is ... Sun Pharma Industries is the top index loser and dragging it to trade in lower levels.
Read more: Live Stock Market Updates – Nifty extends losses, Sensex sheds over 300 points

Pharma Reviews: The State of Pharmaceutical Industry in India – An Overview

In the next three years, India is projected to be among the top three pharmaceutical markets in terms of growth rate and the sixth largest market ...
Read more: The State of Pharmaceutical Industry in India – An Overview

Pharma Reviews: Govt to hold talks with pharma dept-industry on draft pharma policy

Industry bodies including Organization of Pharmaceutical Producers of India (OPPI), the Indian Pharmaceutical Alliance (IPA), the Bulk Drug ...
Read more: Govt to hold talks with pharma dept-industry on draft pharma policy

Pharma Reviews: India needs proper biosupplier ecosystem

Sharing his views on the trends in biosuppliers market, K V Venugopalan, President, Waters India, said” While the pharmaceutical market is expected ...
Read more: India needs proper biosupplier ecosystem

US FDA News: Zenith Alpha Thoracic Endovascular Graft by Cook Medical: Recall Correction and Removal of Specific Sizes from Market - Increased Reports of Graft Thrombosis and Occlusion in BTAI Treatment

Correction removed the indication for BTAI; Voluntary recall includes Zenith Alpha Thoracic products in sizes of 18-22mm, including the 26-22mm tapered device.
Read more: Zenith Alpha Thoracic Endovascular Graft by Cook Medical: Recall Correction and Removal of Specific Sizes from Market - Increased Reports of Graft Thrombosis and Occlusion in BTAI Treatment

Pharma Reviews: Draft Pharmaceutical Policy 2017: 'Recognising drug quality concerns in India signals paradigm shift'

The Draft Pharmaceutical Policy 2017, prepared by the Department of ... Indian industry because they cannot compete with the Indian pharmaceutical ...
Read more: Draft Pharmaceutical Policy 2017: 'Recognising drug quality concerns in India signals paradigm shift'

Pharma Reviews: USFDA observations: To improve report cards, comprehensive reforms must for domestic ...

Exports by the Indian pharmaceutical industry to the US — its biggest market — grew around 28 per cent in 2015-16. However, in 2016-17, the growth ...
Read more: USFDA observations: To improve report cards, comprehensive reforms must for domestic ...

Pharma Reviews: Hospital stocks better placed than pharma peers in healthcare space

For most Indian pharmaceutical companies, the US is the biggest market, accounting for almost half their revenue. The business environment in the ...
Read more: Hospital stocks better placed than pharma peers in healthcare space

Pharma Reviews: Hopes dim for a serious dialogue with the industry on new pharma policy

Talk to any Indian pharmaceutical maker and there are number of questions on how the policy can actually support the industry and meet its larger ...
Read more: Hopes dim for a serious dialogue with the industry on new pharma policy

Pharma Reviews: Pharma Literati launches online certificate course in pharmaceutical intellectual property rights

Pharma Literati launches online certificate course in pharmaceutical ... IPR: With specific reference to pharma; IPR: Indian patent scenario and Patent ...
Read more: Pharma Literati launches online certificate course in pharmaceutical intellectual property rights

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine

One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of development, hold significant promise for transformative and potentially curative treatments for some of humanity’s most troubling and intractable maladies. Recent advances in our basic knowledge of the pathways involved in tissue damage and regeneration have combined with remarkable progress in adult stem cell biology to put us at a genuine inflection point in the history of medicine. The prospect of clinical tissue repair strategies is a tangible reality. This promise is reinforced by the strong commitment of the investment and scientific communities in exploring the potential applications across a wide range of vexing diseases and conditions, such as cancer, Parkinson’s disease, and diabetes, among many others.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine

Pharma Reviews: Sun Pharmaceuticals - A Specialty player

Sun Pharmaceuticals (SUNP) is one of the fastest growing companies in India as well as globally. It is the world's fourth largest specialty generic ...
Read more: Sun Pharmaceuticals - A Specialty player

US FDA News: FDA warns US Stem Cell Clinic of significant deviations

The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic of Sunrise, Florida, and its Chief Scientific Officer Kristin Comella for marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that could impact the sterility of their products, putting patients at risk.
Read more: FDA warns US Stem Cell Clinic of significant deviations

US FDA News: FDA acts to remove unproven, potentially harmful treatment used in ‘stem cell’ centers targeting vulnerable patients

The U.S. Food and Drug Administration took decisive action to prevent the use of a potentially dangerous and unproven treatment belonging to StemImmune Inc. in San Diego, California, and administered to patients at the California Stem Cell Treatment Centers in Rancho Mirage and Beverly Hills, California. On behalf of the FDA, on Friday, Aug. 25, 2017 the U.S. Marshals Service seized five vials of Vaccinia Virus Vaccine (Live) – a vaccine that is reserved only for people at high risk for smallpox, such as some members of the military. Each of the vials originally contained 100 doses of the vaccine, and although one vial was partially used, four of the vials were intact.
Read more: FDA acts to remove unproven, potentially harmful treatment used in ‘stem cell’ centers targeting vulnerable patients

Pharma Reviews: Investor files class action lawsuit against Dr. Reddy's in US

Indian pharmaceutical companies, which supply about 40% of the generic drugs sold in the US, have come under the FDA's scrutiny over issues ...
Read more: Investor files class action lawsuit against Dr. Reddy's in US

Pharma Reviews: Draft pharma policy a bunch of Stalinist contradictions

The government has floated a draft pharmaceutical policy, which they should take note of considering India is the second biggest market by revenue, ...
Read more: Draft pharma policy a bunch of Stalinist contradictions

Pharma Reviews: DoP's draft pharma Policy meet: Pitch to be made for enabling ecosystem for industry and patient ...

Speaking for domestic drug makers, DG Shah of the Indian Pharmaceutical Alliance says that the policy seems to want to do away with retail prices by ...
Read more: DoP's draft pharma Policy meet: Pitch to be made for enabling ecosystem for industry and patient ...

Pharma Reviews: Use of Ayurveda ingredients will see a quantum jump in pharma & cosmetic use: Dr DBA Narayana

This is probably because the industry outside the traditional Ayurveda ... these moving across the world, besides the Indian food and pharma industry.
Read more: Use of Ayurveda ingredients will see a quantum jump in pharma & cosmetic use: Dr DBA Narayana

Pharma Reviews: Otsuka licenses Mylan subsidiary to bring MDR TB drug delamanid to India

NEW DELHI: Japanese drugmaker Otsuka Pharmaceutical has granted US-based Mylan's subsidiary an exclusive licence to market its drug ...
Read more: Otsuka licenses Mylan subsidiary to bring MDR TB drug delamanid to India

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s role in ensuring Americans have access to clear and consistent calorie and nutrition information; forthcoming guidance will provide greater clarity and certainty

As a doctor, father and the head of the U.S. Food & Drug Administration, I believe that everyone is entitled to the information they need to make informed decisions about the food they eat. We serve as the nation’s expert on food labeling, which is why Congress entrusted us with the responsibility of crafting predictable, uniform federal standards that will benefit the health of families across America by ensuring access to essential calorie and nutrition information on food and menu labels.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s role in ensuring Americans have access to clear and consistent calorie and nutrition information; forthcoming guidance will provide greater clarity and certainty

Pharma Reviews: Impact of GST on Pharmaceutical Industry

To sum it up, pharmaceutical industry in India is over USD 100 billion and at any point of time 15-18% hold in the inventory section. So, even a 3-4% ...
Read more: Impact of GST on Pharmaceutical Industry

Pharma Reviews: Hyderabad to witness, 1st promotional tour on India's largest trade fair on environmental ...

Recent cases have shown that the Indian pharma Industry is still facing majorenvironmental challenges, like un-disposed waste, untreated sewage or ...
Read more: Hyderabad to witness, 1st promotional tour on India's largest trade fair on environmental ...

Pharma Reviews: The numbers of small molecules are coming down and the industry is concentrating on biologics ...

As far as Indian pharma companies are concerned, all these years everybody was concentrating in developing generic drugs. The generic drugs do ...
Read more: The numbers of small molecules are coming down and the industry is concentrating on biologics ...

Pharma Reviews: Govt's proposed pharma marketing rules hit law ministry roadblock

India's plan to bring in marketing rules to curb unethical promotional practices in the country's drug industry faces an indefinite delay after it hit a legal ...
Read more: Govt's proposed pharma marketing rules hit law ministry roadblock

Pharma Reviews: China agrees to tackle trade imbalance

On several occasions, New Delhi had pointed out to Beijing that many Indian products, including from agricultural and pharmaceutical sectors, were ...
Read more: China agrees to tackle trade imbalance

Pharma Reviews: Time right to invest in pharma funds via SIPs, says HDFC Securities

There are two Key risks that are weighing on pharma sector since the last ... Inorganic growth can help Indian pharma firms access new markets and ...
Read more: Time right to invest in pharma funds via SIPs, says HDFC Securities

Pharma Reviews: Live Sensex and Nifty coverage: Sensex largely flat; up seventh week in eight

Shares of Indian pharmaceutical companies such as Cadila Healthcare, Lupin Ltd and Sun Pharmaceutical Industries gain between 4.10 pct and 8.9 ...
Read more: Live Sensex and Nifty coverage: Sensex largely flat; up seventh week in eight

Pharma Reviews: Markets end at dull note, pharma, Infosys shares witness jump

Indian shares ended little changed on Thursday as gains in IT and ... Pharmaceutical stocks were the top gainers on both indices, while Adani Ports, ...
Read more: Markets end at dull note, pharma, Infosys shares witness jump

Pharma Reviews: 8 Indian companies in Forbes Asia's 'Fab 50' 2017 list; China dominates once again

India had eight companies on the list last year too. The notable dropouts from 2016 include Tech Mahindra, Aurobindo Pharma, Sun Pharmaceutical ...
Read more: 8 Indian companies in Forbes Asia's 'Fab 50' 2017 list; China dominates once again

Pharma Reviews: Indian Pharma Sector: Time For A More Complex Game

With its cheap copies, India turned into the pharmacy of the world. But it's time to move beyond exporting vanilla generics and on to manufacturing ...
Read more: Indian Pharma Sector: Time For A More Complex Game

Pharma Reviews: Pharma stocks aid fails to boost Sensex; Infosys recoils, HDFC Bank, Reliance Industries drop

Shares of the blue-chip companies Infosys, L&T, Sun Pharma and Tata Motors, Lupin and State Bank of India were the top contributors in uplifting the ...
Read more: Pharma stocks aid fails to boost Sensex; Infosys recoils, HDFC Bank, Reliance Industries drop

Pharma Reviews: Pharma sector funds continue to bleed. Is it time to quit?

Sonam Udasi, fund manager, Tata India Pharma & HealthCare Fund, believes the pharma sector does not look attractive in the near term but he ...
Read more: Pharma sector funds continue to bleed. Is it time to quit?

Pharma Reviews: Sensex bounces 100 points in opening trade; Infosys, Sun Pharma, Tata Motors lead the index

Indian stock market opened higher on Wednesday tracking Asian stocks which edged up in the early trade today. BSE Sensex rose over 100 points to ...
Read more: Sensex bounces 100 points in opening trade; Infosys, Sun Pharma, Tata Motors lead the index

Pharma Reviews: These 10 pharma stocks' PE trade at a discount of over 20% to 5-year average

The Indian pharma sector has been going through one of its low points of late. Even as the US regulator tightened its noose around Indian pharma ...
Read more: These 10 pharma stocks' PE trade at a discount of over 20% to 5-year average

Pharma Reviews: Market Live: Sensex, Nifty rangebound; Lupin, Sun Pharma, Aurobindo top gainers

Healthcare stocks were in demand as Aurobindo Pharma, Lupin, Sun ... 11:35 am Order win: Shares of Indian Hume Pipe Company advanced nearly ...
Read more: Market Live: Sensex, Nifty rangebound; Lupin, Sun Pharma, Aurobindo top gainers

Pharma Reviews: Bengaluru will soon become electric vehicle capital of India, says Minister for Industries

Other major companies that have decided to invest are SAP Labs India Pvt Ltd (Rs 499 crore), Acebright India Pharma Ltd (Rs 492 cr), Desano ...
Read more: Bengaluru will soon become electric vehicle capital of India, says Minister for Industries

Pharma Reviews: IFAT India to focus on pharma issues

Hyderabad: on IFAT India, India's largest trade fair on environmental technologies, will focus on several environmental issues across different industry ...
Read more: IFAT India to focus on pharma issues

Pharma Reviews: Govt's proposed pharma marketing rules hit legal roadblock

Mumbai: India's plan to bring in marketing rules to curb unethical promotional practices in the country's drug industry faces an indefinite delay after it ...
Read more: Govt's proposed pharma marketing rules hit legal roadblock

Pharma Reviews: India's proposed pharma marketing rules hit legal roadblock

MUMBAI (Reuters) - India's plan to bring in marketing rules to curb unethical promotional practices in the country's drug industry faces an indefinite ...
Read more: India's proposed pharma marketing rules hit legal roadblock

US FDA News: Ninjacof and Ninjacof A: Recall - Potential Burkholderia Cepacia Contamination

Use of a product that may contain B. cepacia could result in infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Read more: Ninjacof and Ninjacof A: Recall - Potential Burkholderia Cepacia Contamination

Pharma Reviews: India grants Pfizer patent for pneumonia vaccine

New Delhi: India has granted US pharmaceutical company Pfizer Inc. a patent for its pneumonia vaccine Prevnar 13, in spite of opposition from the ...
Read more: India grants Pfizer patent for pneumonia vaccine

Pharma Reviews: RSS Affiliate Writes to Government on Department of Pharmaceuticals, Alleges Industry Collusion

The letter raises four major issues, with the bulk of the focus on India's drug price regulator, the National Pharmaceutical Pricing Agency (NPPA).
Read more: RSS Affiliate Writes to Government on Department of Pharmaceuticals, Alleges Industry Collusion

Pharma Reviews: Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure; uproar sparked ...

The granting of this patent would block manufacturers in India, including Aurobindo Pharma, Panacea Biotech, BE and Serum Institute, from supplying ...
Read more: Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure; uproar sparked ...

Pharma Reviews: Pfizer Gets Patent For Pneumonia Vaccine in India

New Delhi: Multinational drug major Pfizer Inc on Tuesday said it has been granted patent in India for its vaccine Prevenar 13, used for protection ...
Read more: Pfizer Gets Patent For Pneumonia Vaccine in India

Pharma Reviews: Sensex, Nifty end flat; DRL, Sun Pharma up 2% each

Major gainers in the 30-share index were Dr Reddy'S Laboratories (2.67%), Sun Pharmaceutical Industries (2.24%), Bharti Airtel (1.43%), GAIL (India) ...
Read more: Sensex, Nifty end flat; DRL, Sun Pharma up 2% each

Pharma Reviews: Amid opposition, India gives Pfizer the patent to exclusively sell vital pneumonia vaccine

India has granted Mumbai-based pharmaceutical company Pfizer Inc a patent for its pneumonia vaccine Prevenar 13, amid opposition from groups ...
Read more: Amid opposition, India gives Pfizer the patent to exclusively sell vital pneumonia vaccine

Pharma Reviews: India grants pharma major Pfizer patent on pneumonia vaccine in big blow to poor patients

The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India ...
Read more: India grants pharma major Pfizer patent on pneumonia vaccine in big blow to poor patients

Pharma Reviews: Overcoming dependency on China...

Such a plan is very much essential as India's drug industry depends heavily on large scale imports of active pharmaceutical ingredients (APIs). As per ...
Read more: Overcoming dependency on China...

Pharma Reviews: India looks expensive with downgraded earnings; underweight on IT, pharma: JPMorgan

Adrian Mowat, JPMorgan is underweight on IT, pharma and consumer staples ... He feels India is an expensive market with downgraded earnings.
Read more: India looks expensive with downgraded earnings; underweight on IT, pharma: JPMorgan

Pharma Reviews: Public hearing on Rs 5157-cr Hyderabad Pharma City project next month

Once touted as the bulk drug capital of India, Hyderabad is expected to attract massive investments from Indian and foreign pharma companies facing ...
Read more: Public hearing on Rs 5157-cr Hyderabad Pharma City project next month

Pharma Reviews: Sun Pharma: 1QFY2018 Result Update - Angel Broking

Outlook and valuation: Sun Pharma is one of the largest and fastest growing Indian pharmaceutical companies. We expect its net sales to post a ...
Read more: Sun Pharma: 1QFY2018 Result Update - Angel Broking

Pharma Reviews: "Indian manufacturers account for 60% of vaccine supplies made to UNICEF”

While Indian pharma industry is growing at 10% over the past year, the vaccine industry is growing at 25% between 2011- 2015. The upcoming trends ...
Read more: "Indian manufacturers account for 60% of vaccine supplies made to UNICEF”

Pharma Reviews: Smart Healthcare Paving the Way for a New India

Also healthcare industry leaders, experts, CEOs and other important ... two most promising sector of the Indian economy — Food and Pharmaceuticals ...
Read more: Smart Healthcare Paving the Way for a New India

Pharma Reviews: Draft pharma policy disappoints industry

The draft of the new pharmaceutical policy has not impressed the Indian pharma industry. "I am unable to find anything significant in the policy that is ...
Read more: Draft pharma policy disappoints industry

Pharma Reviews: Big pharma, IP wars and profit over people

Like most FTAs that involve India, the pharmaceutical-hosting countries, like Japan and South Korea, want India to rein in its thriving generic industry, ...
Read more: Big pharma, IP wars and profit over people

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is carefully evaluating prescription opioid medications approved to treat cough in children

There’s perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. For that reason, I believe it’s important that parents and health care providers have the best information available to inform the decisions they make about a child’s health. There are few more common decisions that parents and providers are asked to make than the question of how to appropriately treat a child’s cough and cold symptoms. Sometimes symptoms can be severe enough that prescription medication is needed, but some of these medications pose their own risks – especially for younger children – because they may contain opioids. Other times medication might not be necessary at all.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is carefully evaluating prescription opioid medications approved to treat cough in children

Pharma Reviews: Pharma Policy: Right diagnosis, doubtful prescription

If finalised in its current form, the policy can lead to a major shakeup in Indian pharmaceutical industry as it proposes to end the practice of contract ...
Read more: Pharma Policy: Right diagnosis, doubtful prescription

Pharma Reviews: FDC Eyes Untapped Markets to Boost Revenue

The Indian Pharmaceutical Market (IPM) grew by 10.3 percent to reach the market size of Rs 1,11,135 crore and around 3,297 products were ...
Read more: FDC Eyes Untapped Markets to Boost Revenue

Pharma Reviews: Draft Pharmaceutical Policy revolves more around NPPA & drug price mechanisms, but with new ...

This is evident by the importance of drug pricing given under Para 5.18, stated ... It is high time that Indian pharma sector creates dedicated Ministry of ...
Read more: Draft Pharmaceutical Policy revolves more around NPPA & drug price mechanisms, but with new ...

Pharma Reviews: Industry wary over government's new pharma policy

Mumbai: India's proposed pharmaceutical policy, if implemented in the current form, may have a negative impact on growth and profitability of the ...
Read more: Industry wary over government's new pharma policy

Pharma Reviews: Govt plans bulk drugs manufacturing plants, import curbs to boost domestic production

In a bid to revive India's active pharmaceutical ingredient (API) and bulk drug market, the government is contemplating restrictions on the import of ...
Read more: Govt plans bulk drugs manufacturing plants, import curbs to boost domestic production

Pharma Reviews: Lupin: Under pressure - Hold

The Indian pharmaceutical industry has been going through a tough phase over the last couple of years. While the Nifty 50 index has gained over 15 ...
Read more: Lupin: Under pressure - Hold

Pharma Reviews: New Draft Pharma Policy Shows Interest in Price Regulation, but Also in Crimping Price Regulator

It first says, “It is high time therefore for formulation of a comprehensive pharmaceutical policy to guide and nurture the pharmaceutical industry of India ...
Read more: New Draft Pharma Policy Shows Interest in Price Regulation, but Also in Crimping Price Regulator

Pharma Reviews: FDC eyes untapped markets to boost revenue

The Indian Pharmaceutical Market (IPM) grew by 10.3 per cent to reach the market size of Rs 1,11,135 crore and around 3,297 products were ...
Read more: FDC eyes untapped markets to boost revenue

Pharma Reviews: This week in pharma: Govt unveils draft pharmaceutical policy, NPPA caps prices of knee implants

The Indian drug price regulator the National Pharmaceutical Pricing Authority (NPPA) capped the prices of ortho knee implants citing public interest.
Read more: This week in pharma: Govt unveils draft pharmaceutical policy, NPPA caps prices of knee implants

Product Recall Alerts: Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to

Bella Pharmaceuticals is voluntarily recalling all lots of unexpired sterile drug products due to lack of sterility assurance. The recalled products were ...
Read more: Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to

Pharma Reviews: Wallets To Stop Bullets

During the same year, India's exports to China were worth just $10.2 billion—a ... However, the pharma industry faces several challenges in China.
Read more: Wallets To Stop Bullets

Pharma Reviews: New pharma policy will make drugs cheaper but accessibility remains a concern

According to the newly proposed draft national pharmaceutical policy, the ... Alliance and the Organisation of Pharmaceutical Producers of India.
Read more: New pharma policy will make drugs cheaper but accessibility remains a concern

Pharma Reviews: Tougher foreign investment norms for pharma companies likely

NEW DELHI: In a move to protect the Indian drug manufacturing sector, the government is contemplating tougher foreign investment norms for ...
Read more: Tougher foreign investment norms for pharma companies likely

Pharma Reviews: Taking aim at China, India tightens power grid, telecom rules

India is tightening the rules for businesses entering its power transmission sector and ... India has also privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group`s proposed $1.3 billion takeover of Indian ...
Read more: Taking aim at China, India tightens power grid, telecom rules

US FDA News: Sterile Drug Products by Bella Pharmaceuticals: Recall - Lack of Sterility Assurance

Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.
Read more: Sterile Drug Products by Bella Pharmaceuticals: Recall - Lack of Sterility Assurance

Pharma Reviews: 'Flawed' draft pharma policy likely to hit growth and profits, warns industry body

Indian Pharmaceutical Alliance, the lobby group that represents large Indian drug makers on Friday called the Draft Pharmaceutical Policy 2017 as ...
Read more: 'Flawed' draft pharma policy likely to hit growth and profits, warns industry body

Pharma Reviews: National Pharma Policy draft aims to boost domestic manufacturing of drugs

This step could be marked as the beginning of a new era in Indian pharmaceutical sector. The policy also talks about setting up of a National ...
Read more: National Pharma Policy draft aims to boost domestic manufacturing of drugs

Pharma Reviews: Growing pharma sector to boost laboratory, analysis and diagnostics market in India

The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and is expected ...
Read more: Growing pharma sector to boost laboratory, analysis and diagnostics market in India

Pharma Reviews: Centre's understanding of pharma industry wrong, not surprising draft policy so flawed

Over the years, with more and more of the Indian pharmaceuticals industry subjected to different forms of price control, firms have focused more on the ...
Read more: Centre's understanding of pharma industry wrong, not surprising draft policy so flawed

Pharma Reviews: Price cap on Knee implants: Move may affect availability of premium products, say doctors

A DAY after the National Pharmaceutical Pricing Authority (NPPA) ... are concerned that international pharma companies may withdraw from Indian ...
Read more: Price cap on Knee implants: Move may affect availability of premium products, say doctors

Pharma Reviews: Govt proposes to dilute National Pharmaceutical Pricing Authority's powers

D.G. Shah, secretary general of the Indian Pharmaceutical Alliance, said that the draft policy proposals will suffocate the industry without benefiting ...
Read more: Govt proposes to dilute National Pharmaceutical Pricing Authority's powers

Pharma Reviews: India may force handset makers to set up servers here to ensure data protection

Reports said India has also objected to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion buyout of Gland Pharma. Besides ...
Read more: India may force handset makers to set up servers here to ensure data protection

US FDA News: FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection

As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.
Read more: FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection

Pharma Reviews: Draft pharma policy dilutes powers of pricing regulator

The industry is also wary of the proposed changes in the law. DG Shah, Secretary General of the Indian Pharmaceutical Alliance said, “This could, ...
Read more: Draft pharma policy dilutes powers of pricing regulator

Pharma Reviews: New pharma policy may fix drug trade margins

At present, the National Pharmaceutical Pricing Authority (NPPA) is in the process ... for marketing a mandatory requirement for companies operating in India. ... The pharma pricing watchdog will now have more than 60 days to fix a ...
Read more: New pharma policy may fix drug trade margins

US FDA News: FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Read more: FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Pharma Reviews: Government's role in ensuring access to drugs is very important: Mira Shiva of AIDAN

CNBC-TV18's Archana Shukla caught up with DG Shah, Secretary General of The Indian Pharmaceutical Alliance, SV Veeramani, Former President of ...
Read more: Government's role in ensuring access to drugs is very important: Mira Shiva of AIDAN

Pharma Reviews: Questions that global generic behemoth Teva's results raise for Indian pharma

On August 3rd, the largest generic company operating in the US, Teva Pharmaceutical Industries (Teva in quickspeak) put out results that arguably ...
Read more: Questions that global generic behemoth Teva's results raise for Indian pharma

Pharma Reviews: Why India must take China's warning of a trade war seriously

But it warned that a trade war between China and India seemed to be ... India's pharma sector has critical dependence on Chinese imports used in drugs ... Power is another sector where India has come to be dependent on Chinese ...
Read more: Why India must take China's warning of a trade war seriously

Pharma Reviews: After heart stents, knee implant prices reduced by up to 69 %

The NPPA notification has tried to plug lacunas used by companies to increase profit margins in the drug trade as well. It has made clear that in case ...
Read more: After heart stents, knee implant prices reduced by up to 69 %

Pharma Reviews: Government proposes a new drugs policy that would give it greater control over medicine pricing

If the draft is accepted, the National Pharmaceutical Pricing Authority, which on Wednesday capped the prices of orthopedic knee ... Prime Minister Narendra Modi addressing the US-Indian Business Council in September 2014.
Read more: Government proposes a new drugs policy that would give it greater control over medicine pricing

Product Recall Alerts: Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate ...

Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in ...
Read more: Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate ...

US FDA News: Zenith Alpha Thoracic Endovascular Graft by Cook Medical: Class I Recall - Potential Formation of Thrombus Inside Device

Thrombus may form inside the device after implantation. Thrombosis or occlusion may lead to serious adverse health consequences, including death.
Read more: Zenith Alpha Thoracic Endovascular Graft by Cook Medical: Class I Recall - Potential Formation of Thrombus Inside Device

US FDA News: Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers

Significant probability of serious health consequences if more than the prescribed dose is dispensed, including: drowsiness causing trauma; increased anxiety; and risk of accidental injury to self or others.
Read more: Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers

Pharma Reviews: Buy Aurobindo, Lupin, Fortis Healthcare: Shahina Mukadam

... to start accumulating with three to five year view because I believe that the US market cannot do without Indian pharmaceutical generic companies.".
Read more: Buy Aurobindo, Lupin, Fortis Healthcare: Shahina Mukadam

Pharma Reviews: Stocks Radar: Adani Transmission, Coal India, Natco Pharma

Stocks Radar: Adani Transmission, Coal India, Natco Pharma ... Shares of the pharmaceutical company gained for the third consecutive trading ...
Read more: Stocks Radar: Adani Transmission, Coal India, Natco Pharma

Product Recall Alerts: Amneal Recalls 13 Lots of Lorazepam Oral

Amneal Pharmaceuticals is voluntarily recalling 13 lots of lorazepam oral ... The product is packaged in an individual carton, with the code: NDC ... the box to alert the patient and other pharmacists that the dropper has been replaced.
Read more: Amneal Recalls 13 Lots of Lorazepam Oral

Pharma Reviews: Pharmexcil urges African lawmakers to recognise Indian Pharmacopoeia

Kini said that India has all the capabilities to manufacturer the highest quality of drugs at an affordable price. At present Indian pharma industry exports ...
Read more: Pharmexcil urges African lawmakers to recognise Indian Pharmacopoeia

Pharma Reviews: Opening bell: Asian markets open higher; RIL, Aurobindo Pharma in news

Aurobindo Pharma Ltd and Intas Pharmaceuticals Ltd are in the race to ... could be the biggest overseas acquisition by an Indian pharma company.
Read more: Opening bell: Asian markets open higher; RIL, Aurobindo Pharma in news

Pharma Reviews: Aurobindo Pharma, Intas in race for Teva's European assets

If either Aurobindo or Intas acquire the assets, it will be the largest outbound pharma deal by an Indian company. The largest so far is Lupin Ltd's ...
Read more: Aurobindo Pharma, Intas in race for Teva's European assets

Pharma Reviews: Lessons from Gorakhpur hospital tragedy

It is an irony that even as India's healthcare industry is one of the biggest sectors — both in terms of ... The Indian pharma sector is also growing fast.
Read more: Lessons from Gorakhpur hospital tragedy

Pharma Reviews: Infosys's driverless golf cart versus Google's autonomous vehicles: How can India become a global ...

India is far removed from the global technology innovation ecosphere. ... not enough as the generics-centered Indian pharmaceutical is finding out.
Read more: Infosys's driverless golf cart versus Google's autonomous vehicles: How can India become a global ...

Product Recall Alerts: Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate ...

The Lorazepam Oral Concentrate, USP 2mg/mL, product is packaged with a ... To avoid any interruption in supply or access to the medication by the ... to alert the patient and other pharmacists that the dropper has been replaced.
Read more: Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate ...

Pharma Reviews: Three CEOs resign from Trump council over Charlottesville

The Pharmaceutical Research and Manufacturers of America, which represents the pharmaceutical industry and lobbies on its behalf in Congress, ...
Read more: Three CEOs resign from Trump council over Charlottesville

Pharma Reviews: Analysts consensus is bearish on pharma stocks – should one buy?

Amidst the global rout in pharma, the only comfort that Indian pharmaceutical companies can take is that they are not the only ones falling. All generic ...
Read more: Analysts consensus is bearish on pharma stocks – should one buy?

Pharma Reviews: Pharma@70: Drug Makers Seek Freedom From Dependence On Chinese Imports And Unforeseen ...

Indian pharmaceuticals and healthcare industry on the eve of Independence Day seeks freedom from the variety of ailments. “Getting freedom from the ...
Read more: Pharma@70: Drug Makers Seek Freedom From Dependence On Chinese Imports And Unforeseen ...

Pharma Reviews: Indian Pharma Market growth declines by 2.4% in July 2017 due to GST implementation

The Indian Pharmaceutical Market growth declined by 2.4 per cent during the month of July 2017 to Rs. 9,280 crore due to the first month of GST roll ...
Read more: Indian Pharma Market growth declines by 2.4% in July 2017 due to GST implementation

Pharma Reviews: Brokerages Cut Sun Pharma's Target Price On US Woes

Most brokerages cut target price for Sun Pharmaceutical Industries Ltd. citing ... Falling domestic sales also weighed down India's largest drugmaker's ...
Read more: Brokerages Cut Sun Pharma's Target Price On US Woes

Pharma Reviews: Surgeons sceptical about indigenous knee implants with likely pharma pricing cap

BENGALURU: WITH the National Pharmaceutical Pricing Authority (NPPA) displaying trade ... The longevity has not been studied in Indian implants.
Read more: Surgeons sceptical about indigenous knee implants with likely pharma pricing cap

Pharma Reviews: Morning News Call - India, August 14

3:00 pm: Godrej industries earnings conference call in Mumbai. ... Sun Pharma reports Q1 loss as generics business suffers India's largest drugmaker ...
Read more: Morning News Call - India, August 14

Pharma Reviews: India's Sun Pharma slumps to over 4-yr low on Q1 loss

Sun Pharmaceutical Industries' shares drop as much as 3.8 pct to 432.7 rupees, their lowest since April 2013. ** Company posted surprise loss of 4.25 ...
Read more: India's Sun Pharma slumps to over 4-yr low on Q1 loss

Pharma Reviews: Stocks of Sun Pharma, DLF, Adani Ports in focus; Coal India, Tata Power Q1 earnings ahead

Stocks of Sun Pharma, DLF, Adani Ports in focus; Coal India, Tata Power Q1 ... About 600 listed companies are expected to release the first quarter ...
Read more: Stocks of Sun Pharma, DLF, Adani Ports in focus; Coal India, Tata Power Q1 earnings ahead

Pharma Reviews: Pharmexcil creates 'Innovation Desk' to promote API production, appoints AV Chainulu as head

“As we already know that more than 80 per cent of Indian pharma industry depends on China for low cost API and other KSMs. In view of this, it has ...
Read more: Pharmexcil creates 'Innovation Desk' to promote API production, appoints AV Chainulu as head

Pharma Reviews: Natco Pharma rated 'Buy' Q1 shows better than expected

Natco Pharma rated 'Buy' Q1 shows better than expected ... India was down 20% y-o-y due to GST but management expects recovery in Q2FY18. ... of significant FDA issues makes it one of the best placed Indian pharma companies.
Read more: Natco Pharma rated 'Buy' Q1 shows better than expected

Pharma Reviews: Indo-Canadian venture radicalises drug research

The pharmaceutical industry has so far been chained to a cycle of creating new ... India brings a complementary strength to the table – its strength in ...
Read more: Indo-Canadian venture radicalises drug research

Pharma Reviews: 'India can occupy sectors China is exiting'

Sometimes, I say, they (India Inc) have a Brahminical attitude and will invest in automobiles, auto parts, software, pharma, petroleum refining, but not in ...
Read more: 'India can occupy sectors China is exiting'

Pharma Reviews: US law firms threaten class action suit against Dr Reddy's

In what could be a big setback for Indian pharma major Dr Reddy's Labs, US based law firms have threatened a class action suit against the company ...
Read more: US law firms threaten class action suit against Dr Reddy's

Pharma Reviews: Indian pharma should explore domestic mfg, not imports; MSMEs can be key players: Assam ...

New Delhi, Aug 12 (KNN) Eyeing at decreasing the volume of imports in the pharmaceuticals and pharma equipment sector, it is essential to focus on ...
Read more: Indian pharma should explore domestic mfg, not imports; MSMEs can be key players: Assam ...

Pharma Reviews: Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma loss

India's pharma companies started reporting quarterly results two weeks ago, with many showing double-digit declines in revenue or profit. Over that ...
Read more: Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma loss

Pharma Reviews: Pharma sector cries foul over GST hit on July sales

The All India Organisation of Chemists and Druggists (AIOCD) data shows that the sector registered a negative growth of 2.4 per cent and sales worth ...
Read more: Pharma sector cries foul over GST hit on July sales

Pharma Reviews: Today online medicine market is growing at an exponential rate: Deepak Tomar

At that time some companies came up with a concept where a user can ... Now the government of India has allowed online pharmacy licenses in few ...
Read more: Today online medicine market is growing at an exponential rate: Deepak Tomar

Pharma Reviews: Pharma equipment manufacturing industry making ground in India to substitute imports

The pharma equipment manufacturing industry in India is slowly making its ground to improve its capacities and capabilities to manufacture high end, ...
Read more: Pharma equipment manufacturing industry making ground in India to substitute imports

Pharma Reviews: BSE Healthcare index touches new yearly low at 12513 points

BSE Healthcare index of 68 major pharmaceutical and healthcare ... from R&D activities are likely to put additional burden on Indian pharma players.
Read more: BSE Healthcare index touches new yearly low at 12513 points

Pharma Reviews: Pharma sector has bright future: Kodela

Minister of Water Resources Devineni Umamaheswara Rao said the rise of Indian pharmaceutical companies in the start-up space opened new vistas ...
Read more: Pharma sector has bright future: Kodela

Pharma Reviews: India's Sun Pharma reports Q1 loss as generics business suffers

Aug 11 (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a surprise quarterly loss on Friday due to one-off legal costs ...
Read more: India's Sun Pharma reports Q1 loss as generics business suffers

Pharma Reviews: 'T' hopes green nod for phase 1 of Pharma city in September

In the light of intense regulatory scrutiny of Indian pharma, Pharmexcil ... Pharma director Madan Mohan Reddy stressed on the need for the industry to ...
Read more: 'T' hopes green nod for phase 1 of Pharma city in September

Pharma Reviews: Indian Pharma to focus on import substitution

Indian Pharmaceuticals Industry MAKE IN INDIA: IT and Industries Ministry principal secretary Jayesh Ranjan (centre) inaugurating the fourth edition ...
Read more: Indian Pharma to focus on import substitution

Pharma Reviews: 69th Indian Pharmaceutical Congress to be held at Chitkara University for three days from ...

The 69th Indian Pharmaceutical Congress (IPC), an international conference hosted by IPC association involving manufacturing, teaching, and other ...
Read more: 69th Indian Pharmaceutical Congress to be held at Chitkara University for three days from ...

Pharma Reviews: Sun Pharma Q1 net loss at Rs 424.92 crore

New Delhi, Aug 11 () Drug major Sun Pharmaceutical Industries today ... Its India sales stood at Rs 1,761 crore, down by 5 per cent over Q1 last fiscal, ...
Read more: Sun Pharma Q1 net loss at Rs 424.92 crore

Pharma Reviews: PharmaLytica 2017 exhibits new trends and innovations in pharma industry

Leading industry experts who took part in the panel discussions delved on the growth phase of the Indian pharma and the challenges the industry is ...
Read more: PharmaLytica 2017 exhibits new trends and innovations in pharma industry

Pharma Reviews: Sun Pharma reports quarterly loss after one-off charge

MUMBAI: India's largest drugmaker Sun Pharmaceutical Industries reported a surprise loss in the first quarter after it was hit by a one-off charge ...
Read more: Sun Pharma reports quarterly loss after one-off charge

Pharma Reviews: PharmaLytica 2017: A Gateway to the Pharma Analytical, Laboratory, Pharma Machinery and ...

On the day one of the PharmaLytica, a series of insightful sessions were organized to discuss the growth phase of the Indian pharma industry, the ...
Read more: PharmaLytica 2017: A Gateway to the Pharma Analytical, Laboratory, Pharma Machinery and ...

Pharma Reviews: Sun Pharma posts surprise loss in June-quarter

Sun Pharma posts surprise loss in June-quarter ... India`s largest drugmaker Sun Pharmaceutical Industries posted a surprise loss in the first quarter.
Read more: Sun Pharma posts surprise loss in June-quarter

Pharma Reviews: 39 stocks from BSE 500 index hit 52-week lows

TVS Motors, Sun Pharmaceutical Industries, Dr Reddy's Laboratories, Coal India, Amara Raja Batteries and Reliance Power are among 39 stocks ...
Read more: 39 stocks from BSE 500 index hit 52-week lows

Product Recall Alerts: FDA: Liquid medications recalled due to possible bacteria contamination

Liquid pharmaceutical products from three companies, including some labeled for infants and toddlers, are being recalled due to possible ...
Read more: FDA: Liquid medications recalled due to possible bacteria contamination

US FDA News: FDA warns of potential contamination in multiple brands of drugs, dietary supplements

The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.
Read more: FDA warns of potential contamination in multiple brands of drugs, dietary supplements

US FDA News: Pravastatin Sodium Tablets by International Laboratories: Recall - Mislabeling

Common side effects of bupropion include: nausea, vomiting, dry mouth, headache, constipation, sweating, sore throat, diarrhea, dizziness, restlessness, blurry vision. Risk of allergic reactions are possible and could be life threatening.
Read more: Pravastatin Sodium Tablets by International Laboratories: Recall - Mislabeling

US FDA News: Liquid Products Manufactured by PharmaTech and Distributed by Leader Brand, Major Pharmaceuticals, and Rugby Laboratories: Recall - Possible Product Contamination

Reports of B. cepacia infections in patients.
Read more: Liquid Products Manufactured by PharmaTech and Distributed by Leader Brand, Major Pharmaceuticals, and Rugby Laboratories: Recall - Possible Product Contamination

US FDA News: Liquid-filled Intragastric Balloon Systems: Letter to Healthcare Providers - Potential Risks

Five reports of unanticipated deaths that occurred from 2016 to present, in patients with liquid-filled intragastric balloon systems used to treat obesity.
Read more: Liquid-filled Intragastric Balloon Systems: Letter to Healthcare Providers - Potential Risks

US FDA News: Sterile Drug Products from Vital Rx, dba Atlantic Pharmacy and Compounding: FDA Alert - Lack of Sterility Assurance

Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death.
Read more: Sterile Drug Products from Vital Rx, dba Atlantic Pharmacy and Compounding: FDA Alert - Lack of Sterility Assurance

Pharma Jobs: Product Manager

Company: PHENOMENEX INDIA PVT LTD
Qualification: M.Pharm, M.Sc, PhD
Experience: 3 to 5
location: Hyderabad / Secunderabad
Ref: 21121703
Summary: Maintain and manage specific territory by meeting and exceeding sales, gross profit and unit goals. Provide service and technical support to customers on a ....
Read more: Product Manager

Pharma Reviews: Markets reel under shell firm order, Sensex at 3-week low

In the Sensex pack, Sun Pharma was battered the most, plunging 5.13 per cent to an over four-year low, after its US subsidiary Taro Pharmaceutical ...
Read more: Markets reel under shell firm order, Sensex at 3-week low

Pharma Reviews: Sensex, Nifty fall for third day as pharma stocks drag; US-North Korea tensions weigh

Indian stock market fell for the third consecutive session on Wednesday after the banking and pharma stocks slipped in the morning trade followed by ...
Read more: Sensex, Nifty fall for third day as pharma stocks drag; US-North Korea tensions weigh

Pharma Reviews: Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Drugmaker Sun Pharmaceutical Industries' shares slumped as much as 5 percent to their lowest in over four years after unit Taro Pharmaceutical ...
Read more: Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Pharma Reviews: Market Now: Hindalco, Sun Pharma most active stocks in terms of volume

Market Now: Hindalco, Sun Pharma most active stocks in terms of volume .... ICICI Bank (0.16 crore) and State Bank of India (0.16 crore) were among the most ... in negative zone with selling in realty, pharma, bank and FMCG stocks.
Read more: Market Now: Hindalco, Sun Pharma most active stocks in terms of volume

US FDA News: Liquid Drug Products Manufactured by PharmaTech and Distributed by Rugby Laboratories and Possibly Other Companies: FDA Advisory - Not to Use

Advisory due to Burkholderia cepacia contamination and the potential for severe patient infection.
Read more: Liquid Drug Products Manufactured by PharmaTech and Distributed by Rugby Laboratories and Possibly Other Companies: FDA Advisory - Not to Use

Pharma Reviews: DCGI mulls alternatives to China active pharmaceutical ingredients

MUMBAI: The Drug Controller General of India (DCGI) has got local drugmakers to draw up an emergency plan on dealing with any blockade on ...
Read more: DCGI mulls alternatives to China active pharmaceutical ingredients

US FDA News: FDA to expand public education campaign to focus on prevention of youth e-cigarette use

Today, the U.S. Food and Drug Administration announced it would pursue a strategic, new public health education campaign aimed at discouraging the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) by kids. The agency plans to expand its “The Real Cost” public education campaign to include messaging to teens about the dangers of using these products this fall while developing a full-scale campaign to launch in 2018. These efforts are part of the agency’s new comprehensive plan for tobacco and nicotine regulation, as well as ongoing efforts to educate youth about, and protect them from, the dangers associated with using all tobacco products. It is the first time the FDA will be utilizing public health education to specifically target youth use of e-cigarettes or other ENDS.
Read more: FDA to expand public education campaign to focus on prevention of youth e-cigarette use

Pharma Reviews: Digital transformation of global pharma companies in India is critical, says Charles Houdoux

New Delhi: After acquiring Indian health advertising agency Sorento in May, Havas Group has launched its decade-old global health agency Health ...
Read more: Digital transformation of global pharma companies in India is critical, says Charles Houdoux

Pharma Reviews: Honeywell To Replace Hydrofluorocarbon (HFC) Production

Are there any exclusive partnerships with Indian companies in HVACs and cooling solutions, pharma and oil and gas? How are you supporting 'Make ...
Read more: Honeywell To Replace Hydrofluorocarbon (HFC) Production

Pharma Reviews: Rupee rise to bring to fore hedging strategies of Indian companies

Agrawal's fears can be validated by the fact that several large IT and pharma companies' earnings are highly inversely related to the rupee's strength.
Read more: Rupee rise to bring to fore hedging strategies of Indian companies

Pharma Reviews: US based NSF International Adds Pharma Biotech Services To India Office

The addition of these consulting and technical services is a response to demands of India's growing pharmaceutical industry, the company informed in ...
Read more: US based NSF International Adds Pharma Biotech Services To India Office

Pharma Reviews: Fourth edition of PharmaLytica 2017 to be held in Hyderabad from 11 to 12 August

“Comprehensive industry platforms like PharmaLytica acts as catalysts, transforming India to an end-to-end, research & innovation-driven biotech ...
Read more: Fourth edition of PharmaLytica 2017 to be held in Hyderabad from 11 to 12 August

Pharma Reviews: India and Sweden trying to take their 'SAMBANDH' to next level

Many Indian IT companies have opened offices in Sweden. Indian Pharma and Biotech companies are also present. Aditya Birla Group, Wipro, Tata ...
Read more: India and Sweden trying to take their 'SAMBANDH' to next level

Pharma Reviews: NSF International Adds Pharma Biotech Services to India Office

NSF International Adds Pharma Biotech Services to India Office ... "We've been working with India's pharmaceutical industry for several years, but our ...
Read more: NSF International Adds Pharma Biotech Services to India Office

Pharma Reviews: Four pharma clusters to be set up in State: Chandrababu Naidu

During a meeting with representatives of several pharma industries, Pharmaceuticals Export Promotion Council of India and Drugs Control ...
Read more: Four pharma clusters to be set up in State: Chandrababu Naidu

Pharma Reviews: Supreme Court to hear Japanese drugmaker Daiichi Sankyo plea on Aug 11

Daiichi, which is no longer the owner of Ranbaxy after it sold the company to another Indian pharmaceutical major Sun Pharma for $3.2 billion in 2014 ...
Read more: Supreme Court to hear Japanese drugmaker Daiichi Sankyo plea on Aug 11

Pharma Reviews: Indian pharma poised for US acquisitions

The largest Indian pharmaceuticals exporter to the US, Sun Pharmaceutical, had cash and cash equivalent of Rs 8,663 crore at the end of the last ...
Read more: Indian pharma poised for US acquisitions

Pharma Reviews: Biocon developing 10 biosimilars that collectively target global market opportunity of over $60 ...

What are the current key trends in the Indian pharmaceutical industry? ... Since 2008, the Indian biosimilar industry has been growing at a CAGR of ...
Read more: Biocon developing 10 biosimilars that collectively target global market opportunity of over $60 ...

Pharma Reviews: Indian pharma needs to strengthen its know-how in regulations to include cyber security & anti ...

The Indian pharma industry needs to not just keep pace with the regulations for clinical trials and good manufacturing practices, but also those of ...
Read more: Indian pharma needs to strengthen its know-how in regulations to include cyber security & anti ...

Pharma Reviews: 3D thinking will play a vital role in shaping the pharma industry: Kanchana TK

What are the disruptors that will change the pharma industry? ... What we lack today in the global pharmaceutical companies or in India, we don't have ...
Read more: 3D thinking will play a vital role in shaping the pharma industry: Kanchana TK

Pharma Reviews: Pharma major's Cuddalore unit under NGT glare

CHENNAI: Pharmaceutical major Strides Shasun, which has secured the US Food and Drug Administration's approval for its three plants in ...
Read more: Pharma major's Cuddalore unit under NGT glare

Pharma Reviews: What India needs to develop its own innovative R&D focussed pharma and medical devices sector

For India to develop its own innovative R&D focused pharmaceutical and medical devices sector regulators like NPPA need to re-imagine their ...
Read more: What India needs to develop its own innovative R&D focussed pharma and medical devices sector

Pharma Reviews: Create Copy Disrupt: Dilemmas of Locating IP and Development

The first part discusses patents and pharmaceuticals in India after Independence. It narrates how India abolished pharmaceutical patents in 1970 and ...
Read more: Create Copy Disrupt: Dilemmas of Locating IP and Development

Pharma Reviews: Nifty, Sensex Fall; Reliance Industries, Pharma Stocks Weigh

Indian shares fell on Friday, dragged down by Reliance Industries Ltd on profit-taking, while drugmakers declined after the U.S. health regulator found ...
Read more: Nifty, Sensex Fall; Reliance Industries, Pharma Stocks Weigh

Pharma Reviews: Pharmacovigilance needs to be strengthened in India: SV Veeramani

Continuous monitoring of drugs in the market is essential with respect to ... So, Indian pharma industry needs a strong pharmacovigilance system.
Read more: Pharmacovigilance needs to be strengthened in India: SV Veeramani

US FDA News: Balguti Kesaria Ayurvedic Medicine: FDA Warning - High Levels Of Lead

Exposure to lead can cause serious damage to the central nervous system, the kidneys and the immune system.
Read more: Balguti Kesaria Ayurvedic Medicine: FDA Warning - High Levels Of Lead

Pharma Reviews: Sikkim standoff may derail business progress achieved in recent years

Indian companies across IT and pharmaceutical sectors have been looking to expand their presence in India but face several challenges. The CII ...
Read more: Sikkim standoff may derail business progress achieved in recent years

Pharma Reviews: 'Pharma Bro' Martin Shkreli convicted of US securities fraud

NEW YORK: A US jury on Friday convicted former hedge fund manager and pharmaceutical executive Martin Shkreli, once dubbed "The Most Hated ...
Read more: 'Pharma Bro' Martin Shkreli convicted of US securities fraud

Pharma Reviews: What ails the Centre's generics Rx initiative?

Generics are defined globally as off-patent, less-expensive drugs that are chemically similar to an innovative drug. But the Indian market is dominated ...
Read more: What ails the Centre's generics Rx initiative?

Pharma Reviews: Deregulation Best Way To Create Jobs, R Sukumar Of Franklin Templeton Says

What are the micro trends in India which are exciting you as an equity ... What is your stance on pharma companies in India and have you changed ...
Read more: Deregulation Best Way To Create Jobs, R Sukumar Of Franklin Templeton Says

Pharma Reviews: Hyderabad to host PharmaLytica on Aug 11-12

Hyderabad: Hyderabad, which is one of the major pharmaceutical hubs in the ... Organised by UBM India, the event provides a platform for pharma ...
Read more: Hyderabad to host PharmaLytica on Aug 11-12

Pharma Reviews: Markets may remain bullish in near term; FMCG, IT likely to gain

Indian pharma companies, which had earlier faced regulatory sanctions and warnings over quality control from the US health regulator, had yet ...
Read more: Markets may remain bullish in near term; FMCG, IT likely to gain

Pharma Reviews: Waiving clinical trials for proven drugs can benefit India if done with precautions

This decision is aimed to speed up the availability of new drugs in the Indian pharmaceutical market and to reduce the cost of drugs. It has already ...
Read more: Waiving clinical trials for proven drugs can benefit India if done with precautions

Pharma Reviews: Govt looks to reduce pharma industry's bulk drug imports

The government is working on a strategy to reduce the import dependence of Indian pharmaceutical industry for its raw material needs, as a bulk of the ...
Read more: Govt looks to reduce pharma industry's bulk drug imports

Pharma Reviews: Doka La stand-off: China should fear the brewing trade war, it has more at stake than India

A report in the Hindu Business Line (read here), says the Centre is working to reduce the Indian pharmaceutical industry's dependence on Chinese ...
Read more: Doka La stand-off: China should fear the brewing trade war, it has more at stake than India

Pharma Reviews: Sensex, Nifty continue fall; Reliance Industries, pharma stocks drag

The findings of the US Food and Drug Administration mark another blow to the Indian pharmaceutical industry, which has faced regulatory sanctions ...
Read more: Sensex, Nifty continue fall; Reliance Industries, pharma stocks drag

Pharma Reviews: Pharma stocks crack for third day in a row; should you buy?

Other pharma majors such as Sun Pharmaceutical Industries (down 2.18 ... In the Nifty index, Indian Oil Corporation (up 4.51 per cent), Vedanta (up ...
Read more: Pharma stocks crack for third day in a row; should you buy?

Pharma Reviews: Centre plans to reduce Indian pharma cos' dependence on Chinese imports

The Centre is working on a plan to help decrease the Indian pharmaceutical industry's dependence on raw material imports from China, amid the ...
Read more: Centre plans to reduce Indian pharma cos' dependence on Chinese imports

US FDA News: Compounded Curcumin Emulsion Product for Injection by ImprimisRx: FDA Investigation - Serious Adverse Events Associated with Use

Drug products, including FDA-approved products, containing polyethylene glycol castor oil have been associated with severe and sometimes fatal hypersensitivity reactions.
Read more: Compounded Curcumin Emulsion Product for Injection by ImprimisRx: FDA Investigation - Serious Adverse Events Associated with Use

US FDA News: Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions

U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction yesterday between the United States and Isomeric Pharmacy Solutions of Salt Lake City, Utah, two of the company’s co-owners, William O. Richardson and Rachael S. Cruz, and chief operating officer Jeffery D. Brown.
Read more: Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions

Pharma Reviews: Can truth in vilification be defence against anti-competitive

The CCI order had come on a complaint by two Indian pharma firms, claiming to make bio-similar versions of the Swiss company's breast cancer ...
Read more: Can truth in vilification be defence against anti-competitive

US FDA News: FDA approves Mavyret for Hepatitis C

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype 1 infection who have been previously treated with a regimen either containing an NS5A inhibitor or an NS3/4A protease inhibitor but not both.
Read more: FDA approves Mavyret for Hepatitis C

US FDA News: Diocto Liquid and Diocto Syrup by Rugby Laboratories: Recall - Possible Product Contamination

Use could result in serious or life-threatening infections in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Read more: Diocto Liquid and Diocto Syrup by Rugby Laboratories: Recall - Possible Product Contamination

US FDA News: FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.
Read more: FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

US FDA News: FDA approves treatment for chronic graft versus host disease

The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments. This is the first FDA-approved therapy for the treatment of cGVHD.
Read more: FDA approves treatment for chronic graft versus host disease

Pharma Reviews: BASF India launches pharma technical lab in Maharashtra

"South Asia, especially India, is the largest provider for generic medicines globally and R&D is a major focus for Indian generic pharma companies, ...
Read more: BASF India launches pharma technical lab in Maharashtra

Pharma Reviews: No more freebies? India plans crackdown on marketing by drugmakers

The Indian Pharmaceutical Association (IPA), a lobby group of India's largest drugmakers, said it supports mandatory rules for curbing undesirable ...
Read more: No more freebies? India plans crackdown on marketing by drugmakers

Pharma Reviews: No more freebies: India plans crackdown on marketing by drugmakers

While such rules are common elsewhere in the world and adhered to by large pharmaceutical companies, they are not set in stone in India, where ...
Read more: No more freebies: India plans crackdown on marketing by drugmakers

Pharma Reviews: Vigilant India against Chinese acquisition as deal with Shanghai Fosun Pharmaceutical Group ...

Reportedly, Chinese firm Shanghai Fosun Pharmaceutical Group's proposal of $1.3 billion take over of the Indian drug maker Gland Pharma has ...
Read more: Vigilant India against Chinese acquisition as deal with Shanghai Fosun Pharmaceutical Group ...

Pharma Reviews: Doklam effect? India raises concerns around Chinese firm Fosun's takeover of Gland Pharma

New Delhi: India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group`s proposed $1.3 billion takeover of Indian ...
Read more: Doklam effect? India raises concerns around Chinese firm Fosun's takeover of Gland Pharma

Pharma Reviews: AICDF urges DoP to act against drug makers for not recalling expired stocks

When contacted DG Shah, secretary general of Indian Pharmaceutical Alliance, a representative body of 20 research based pharmaceutical ...
Read more: AICDF urges DoP to act against drug makers for not recalling expired stocks

Pharma Reviews: Doklam Upshot: India closes China gates for Gland Pharma

Doklam Upshot: India closes China gates for Gland Pharma ... Chinese drugmakers are keen on acquiring Indian drug companies that will give them ...
Read more: Doklam Upshot: India closes China gates for Gland Pharma

Pharma Reviews: CCEA yet to take up Gland Pharma deal with Fosun

There have been reports that the CCEA has rejected Chinese firm Shanghai Fosun Pharmaceutical's proposed $1.3 billion takeover of Indian ...
Read more: CCEA yet to take up Gland Pharma deal with Fosun

Pharma Reviews: India Rejects China's 1.3 Billion Dollar Proposal to Buy Gland Pharma Amid Doklam Row

The government stalled the proposal of China's Shanghai Fosun Pharmaceutical to buy an 86 per cent stake in Hyderabad-based Gland Pharma.
Read more: India Rejects China's 1.3 Billion Dollar Proposal to Buy Gland Pharma Amid Doklam Row

Pharma Reviews: India likely to block $1.3 bn Gland Pharma-Fosun deal

India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion takeover of Indian drugmaker ...
Read more: India likely to block $1.3 bn Gland Pharma-Fosun deal

US FDA News: FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

The U.S. Food and Drug Administration today approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is approved for use with a companion diagnostic, the RealTime IDH2 Assay, which is used to detect specific mutations in the IDH2 gene in patients with AML.
Read more: FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

Pharma Reviews: Doklam standoff fallout? Chinese co's $1.3 bn proposal to buy stake in Gland Pharma rejected

Shanghai Fosun Pharmaceutical's plan was to acquire stake in Gland Pharma through its subsidiaries outside India, namely Fosun Pharma Industrial ...
Read more: Doklam standoff fallout? Chinese co's $1.3 bn proposal to buy stake in Gland Pharma rejected

Pharma Reviews: Rs 8450 crore deal: Has Modi govt blocked China's biggest acquisition in India?

India is reportedly likely to reject Shanghai Fosun Pharmaceutical Group's proposed Rs 8,450 crore ($1.3 billion) accusation offer of an Indian ...
Read more: Rs 8450 crore deal: Has Modi govt blocked China's biggest acquisition in India?

Pharma Reviews: Financial services to dominate for some time: Ajay Piramal, Piramal Enterprises

What is your take on the extent of compliance that certain Indian pharma companies now have to compulsorily undergo to satisfy the USFDA?
Read more: Financial services to dominate for some time: Ajay Piramal, Piramal Enterprises

Pharma Reviews: Indian govt may turn down Fosun's offer to acquire Gland Pharma

If reports are to be believed, India is all set to block China's Fosun Pharmaceutical Group's proposed $1.3-billion takeover of drugmaker Gland Pharma ...
Read more: Indian govt may turn down Fosun's offer to acquire Gland Pharma

Pharma Reviews: Most pharma stocks gain

Firm cues from global stocks supported gains on the bourses. However, private survey showing Indian manufacturing activity contracting in July kept ...
Read more: Most pharma stocks gain

Pharma Reviews: Doklam effect? India said to block Fosun's $1.3 billion Gland purchase

India is poised to reject Shanghai Fosun Pharmaceutical Group Co's proposed $1.3 billion takeover of an Indian drugmaker, according to people ...
Read more: Doklam effect? India said to block Fosun's $1.3 billion Gland purchase